94 related articles for article (PubMed ID: 21530566)
1. Desulfohaplosamate, a new phosphate-containing steroid from Dasychalina sp., is a selective cannabinoid CB2 receptor ligand.
Chianese G; Fattorusso E; Taglialatela-Scafati O; Bavestrello G; Calcinai B; Dien HA; Ligresti A; Di Marzo V
Steroids; 2011; 76(10-11):998-1002. PubMed ID: 21530566
[TBL] [Abstract][Full Text] [Related]
2. Functional cell-based screening and saturation transfer double-difference NMR have identified haplosamate A as a cannabinoid receptor agonist.
Pereira A; Pfeifer TA; Grigliatti TA; Andersen RJ
ACS Chem Biol; 2009 Feb; 4(2):139-44. PubMed ID: 19175306
[TBL] [Abstract][Full Text] [Related]
3. Novel 4-oxo-1,4-dihydroquinoline-3-carboxamide derivatives as new CB2 cannabinoid receptors agonists: synthesis, pharmacological properties and molecular modeling.
Stern E; Muccioli GG; Millet R; Goossens JF; Farce A; Chavatte P; Poupaert JH; Lambert DM; Depreux P; Hénichart JP
J Med Chem; 2006 Jan; 49(1):70-9. PubMed ID: 16392793
[TBL] [Abstract][Full Text] [Related]
4. Sulfonamide derivatives as new potent and selective CB2 cannabinoid receptor agonists.
Ohta H; Ishizaka T; Yoshinaga M; Morita A; Tomishima Y; Toda Y; Saito S
Bioorg Med Chem Lett; 2007 Sep; 17(18):5133-5. PubMed ID: 17643986
[TBL] [Abstract][Full Text] [Related]
5. Tricyclic pyrazoles. 4. Synthesis and biological evaluation of analogues of the robust and selective CB2 cannabinoid ligand 1-(2',4'-dichlorophenyl)-6-methyl-N-piperidin-1-yl-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamide.
Murineddu G; Lazzari P; Ruiu S; Sanna A; Loriga G; Manca I; Falzoi M; Dessì C; Curzu MM; Chelucci G; Pani L; Pinna GA
J Med Chem; 2006 Dec; 49(25):7502-12. PubMed ID: 17149879
[TBL] [Abstract][Full Text] [Related]
6. Indol-3-ylcycloalkyl ketones: effects of N1 substituted indole side chain variations on CB(2) cannabinoid receptor activity.
Frost JM; Dart MJ; Tietje KR; Garrison TR; Grayson GK; Daza AV; El-Kouhen OF; Yao BB; Hsieh GC; Pai M; Zhu CZ; Chandran P; Meyer MD
J Med Chem; 2010 Jan; 53(1):295-315. PubMed ID: 19921781
[TBL] [Abstract][Full Text] [Related]
7. Imine derivatives as new potent and selective CB2 cannabinoid receptor agonists with an analgesic action.
Ohta H; Ishizaka T; Tatsuzuki M; Yoshinaga M; Iida I; Yamaguchi T; Tomishima Y; Futaki N; Toda Y; Saito S
Bioorg Med Chem; 2008 Feb; 16(3):1111-24. PubMed ID: 18006322
[TBL] [Abstract][Full Text] [Related]
8. 1-Alkyl-2-aryl-4-(1-naphthoyl)pyrroles: new high affinity ligands for the cannabinoid CB1 and CB2 receptors.
Huffman JW; Padgett LW; Isherwood ML; Wiley JL; Martin BR
Bioorg Med Chem Lett; 2006 Oct; 16(20):5432-5. PubMed ID: 16889960
[TBL] [Abstract][Full Text] [Related]
9. N-Alkylidenearylcarboxamides as new potent and selective CB(2) cannabinoid receptor agonists with good oral bioavailability.
Ohta H; Ishizaka T; Tatsuzuki M; Yoshinaga M; Iida I; Tomishima Y; Toda Y; Saito S
Bioorg Med Chem Lett; 2007 Nov; 17(22):6299-304. PubMed ID: 17884496
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional quantitative structure-selectivity relationships analysis guided rational design of a highly selective ligand for the cannabinoid receptor 2.
Brogi S; Corelli F; Di Marzo V; Ligresti A; Mugnaini C; Pasquini S; Tafi A
Eur J Med Chem; 2011 Feb; 46(2):547-55. PubMed ID: 21183257
[TBL] [Abstract][Full Text] [Related]
11. Rational design, synthesis, and pharmacological properties of new 1,8-naphthyridin-2(1H)-on-3-carboxamide derivatives as highly selective cannabinoid-2 receptor agonists.
Manera C; Saccomanni G; Adinolfi B; Benetti V; Ligresti A; Cascio MG; Tuccinardi T; Lucchesi V; Martinelli A; Nieri P; Masini E; Di Marzo V; Ferrarini PL
J Med Chem; 2009 Jun; 52(12):3644-51. PubMed ID: 19435366
[TBL] [Abstract][Full Text] [Related]
12. Steroids from an Australian sponge Psammoclema sp.
Holland IP; McCluskey A; Sakoff JA; Gilbert J; Chau N; Robinson PJ; Motti CA; Wright AD; van Altena IA
J Nat Prod; 2009 Jan; 72(1):102-6. PubMed ID: 19132863
[TBL] [Abstract][Full Text] [Related]
13. Pharmacomodulations around the 4-oxo-1,4-dihydroquinoline-3-carboxamides, a class of potent CB2-selective cannabinoid receptor ligands: consequences in receptor affinity and functionality.
Stern E; Muccioli GG; Bosier B; Hamtiaux L; Millet R; Poupaert JH; Hénichart JP; Depreux P; Goossens JF; Lambert DM
J Med Chem; 2007 Nov; 50(22):5471-84. PubMed ID: 17915849
[TBL] [Abstract][Full Text] [Related]
14. Cinanthrenol A, an estrogenic steroid containing phenanthrene nucleus, from a marine sponge Cinachyrella sp.
Machida K; Abe T; Arai D; Okamoto M; Shimizu I; de Voogd NJ; Fusetani N; Nakao Y
Org Lett; 2014 Mar; 16(6):1539-41. PubMed ID: 24617666
[TBL] [Abstract][Full Text] [Related]
15. 4-Oxo-1,4-dihydropyridines as selective CB2 cannabinoid receptor ligands: structural insights into the design of a novel inverse agonist series.
El Bakali J; Muccioli GG; Renault N; Pradal D; Body-Malapel M; Djouina M; Hamtiaux L; Andrzejak V; Desreumaux P; Chavatte P; Lambert DM; Millet R
J Med Chem; 2010 Nov; 53(22):7918-31. PubMed ID: 20979417
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.
Showalter VM; Compton DR; Martin BR; Abood ME
J Pharmacol Exp Ther; 1996 Sep; 278(3):989-99. PubMed ID: 8819477
[TBL] [Abstract][Full Text] [Related]
17. The application of 3D-QSAR studies for novel cannabinoid ligands substituted at the C1' position of the alkyl side chain on the structural requirements for binding to cannabinoid receptors CB1 and CB2.
Durdagi S; Kapou A; Kourouli T; Andreou T; Nikas SP; Nahmias VR; Papahatjis DP; Papadopoulos MG; Mavromoustakos T
J Med Chem; 2007 Jun; 50(12):2875-85. PubMed ID: 17521177
[TBL] [Abstract][Full Text] [Related]
18. Discovery of a novel class of selective human CB1 inverse agonists.
Foloppe N; Allen NH; Bentley CH; Brooks TD; Kennett G; Knight AR; Leonardi S; Misra A; Monck NJ; Sellwood DM
Bioorg Med Chem Lett; 2008 Feb; 18(3):1199-206. PubMed ID: 18083560
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and SAR of novel imidazoles as potent and selective cannabinoid CB2 receptor antagonists with high binding efficiencies.
Lange JH; van der Neut MA; Wals HC; Kuil GD; Borst AJ; Mulder A; den Hartog AP; Zilaout H; Goutier W; van Stuivenberg HH; van Vliet BJ
Bioorg Med Chem Lett; 2010 Feb; 20(3):1084-9. PubMed ID: 20031412
[TBL] [Abstract][Full Text] [Related]
20. Indol-3-yl-tetramethylcyclopropyl ketones: effects of indole ring substitution on CB2 cannabinoid receptor activity.
Frost JM; Dart MJ; Tietje KR; Garrison TR; Grayson GK; Daza AV; El-Kouhen OF; Miller LN; Li L; Yao BB; Hsieh GC; Pai M; Zhu CZ; Chandran P; Meyer MD
J Med Chem; 2008 Mar; 51(6):1904-12. PubMed ID: 18311894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
